Precigen, Inc.

About Precigen, Inc.

Precigen is a company focused on advancing medicine with precision, aiming to innovate and improve healthcare through targeted therapeutic and technology platforms.

Products & Services

PAPZIMEOS (zopapogene imadenovec-drba):A subcutaneous injection (5×10^11 PU/mL) recently approved in the US for adults with recurrent respiratory papillomatosis (RRP), representing a novel immunotherapy.

Precigen Pipeline:A range of therapeutic solutions under development, with details available on their pipeline page.

Specialties

Therapeutic Platforms Technology Platforms Immunotherapy Precision Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 125000000 MR: - FA: $125 million FAN: 125000000	D: 2025-09-02 FD: 2025-09-02	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 79000000 MR: - FA: $79.0 million FAN: 79000000	D: 2024-12-27 FD: 2024-12-27	4 investors
3	RT: Public Offering T: - FT: Public Offering	A: 30000000 MR: - FA: $30.0 million FAN: 30000000	D: 2024-08-07 FD: 2024-08-07	1 investors
4	RT: Public Offering T: - FT: Public Offering	A: 30000000 MR: - FA: $30.0 million FAN: 30000000	D: 2024-08-06 FD: 2024-08-06	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 75000000 MR: - FA: approximately $75.0 million FAN: 75000000	D: 2023-01-27 FD: 2023-01-27	4 investors
6	RT: Public Offering T: - FT: Public Offering	A: 75000000 MR: - FA: $75.0 million FAN: 75000000	D: 2023-01-24 FD: 2023-01-24	4 investors

Debt Latest

2025-09-02

$125.0M

1 investor (Pro only)

Private Placement 2024-12-27

$79.0M

Public Offering 2024-08-07

$30.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Helen Sabzevari

President and CEO

R

Rutul R. Shah

Chief Operating Officer

P

Phil Tennant

Chief Commercial Officer

H

Harry Thomasian Jr.

Chief Financial Officer

D

Douglas E. Brough

SVP, Head of Research

B

Bryan T. Butman, PhD

SVP, Head of CMC

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Precigen, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised